
|Videos|April 7, 2021
Opioid-free ureteroscopy initiatives appear to be reducing new-persistent opioid use
Author(s)Urology Times staff
“This paper shows that our efforts to reduce… opioid exposure in the postoperative setting is reducing new persistent opioid use,” says Matthew S. Lee, MD.
Advertisement
In this video, Matthew S. Lee, MD, discusses the recent Urology paper, “Opioid Free Ureteroscopy: what is the true failure rate?” for which he served as a study author. Lee was an endourology fellow at Indiana University at the time of the study and is currently a clinical instructor at Northwestern University Feinberg School of Medicine.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












